Investing.com-- U.S. stock futures edged lower Thursday evening as investors assessed Apple and Amazon earnings reflecting tariff concerns, while Wall Street saw gains in regular trading, helped by robust results from Microsoft and Meta a day earlier.
S&P 500 Futures inched 0.2% lower to 5,612.25 points, while Nasdaq 100 Futures fell 0.4% to 19,798.75 points by 20:02 ET (00:02 GMT). Dow Jones Futures dipped 0.1% at 40,838.0 points.
Apple flags tariff hit, Amazon’s forecast disappoints
Shares of iPhone-maker Apple (NASDAQ: AAPL ) fell 3.8% in extended trading on Thursday after the company said it sees about $900 million in costs for the upcoming quarter due to tariffs.
Apple posted fiscal second-quarter results that topped Wall Street estimates on better-than-expected iPhone sales, but tariff concerns dented optimism.
Meanwhile, Amazon (NASDAQ: AMZN ) reported softer guidance for the current quarter and underwhelming growth in its key cloud computing segment.
Amazon forecast second-quarter operating income of between $13.0 billion and $17.5 billion, missing estimates of $17.82 billion.
Amazon shares declined nearly 3% after the bell.
Wall St jumped on strong Meta, Microsoft earnings
In the regular trading session on Thursday, the Dow Jones Industrial Average closed 0.2% higher, while the S&P 500 gained 0.6%, and the NASDAQ Composite jumped 1.5%.
Meta Platforms Inc (NASDAQ: META ) shares jumped more than 4% after quarterly results and guidance topped consensus. The parent company of Facebook and Instagram anticipated full-year 2025 capital expenditures in the range of $64-$72 billion, increased from their prior guidance of $60-65 billion.
Microsoft Corporation (NASDAQ: MSFT ) shares surged more than 7% after the software giant’s first-quarter revenue increased 13%. It also forecast cloud-computing revenue growth of 34% to 35% for the fiscal fourth quarter.
Elsewhere, McDonald’s (NYSE: MCD ) stock slipped over 1% after reporting an unexpected drop in Q1 global sales, while Eli Lilly (NYSE: LLY ) shares declined 11% on weak sales of its weight-loss drug Zepbound.
Meanwhile, data showed that initial jobless claims rose by 18,000 last week, signaling a possible uptick in layoffs from tariffs ahead of Friday’s nonfarm payrolls report.